Skip to content

    Outlook Therapeutics (OTLK) stock price & financials

    View OTLK earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance73.1% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $1.51M
    Operating Profit
    -$22.88M
    -$21.61M
    -$12.39M
    -$15.75M
    -$17.31M
    +24.3%
    -$13.48M
    +37.6%
    -$14.03M
    -13.2%
    -$10.81M
    +31.4%
    Strengthening
    Net Profit
    $5.69M
    $17.38M
    -$46.36M
    -$20.15M
    -$13.29M
    -333.6%
    -$23.06M
    -232.7%
    -$4.45M
    +90.4%
    -$20.32M
    -0.8%
    Weakening
    EPS
    $0.72
    $-1.50
    $-0.55
    $-0.38
    -152.8%
    $-0.05
    +96.7%
    $-0.15
    +72.7%
    Strengthening
    Other Income
    Interest
    Depreciation
    Profit before Tax
    -$46.35M
    -$20.15M
    -$4.45M
    +90.4%
    -$20.32M
    -0.8%
    Strengthening
    MarginsOPM
    -1046.2%
    Tax
    -0.0%
    ReturnsROIC
    -0.9%
    -2.7%
    7.1%
    3.1%
    2.0%
    3.5%
    0.7%
    -90.4%
    3.1%
    +0.8%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$1.72M$8.02M$12.54M$14.48M$17.40M$23.39M$14.93M$8.08M$11.24M
    Short-Term Investments
    Total Current Assets$3.30M$13.50M$17.94M$21.51M$27.52M$30.98M$27.42M$17.39M$23.17M
    Net PP&E$18.49M$3.18M$494.2K$275.1K$70.4K$26.2K$274.6K$225.5K$185.2K
    Goodwill
    Intangibles
    Total Assets$22.28M$17.13M$19.73M$22.81M$28.53M$32.30M$28.82M$18.58M$26.18M
    LiabilitiesTotal Current Liabilities$32.04M$20.29M$15.89M$6.75M$19.73M$46.73M$42.55M$45.81M$28.68M
    Short-Term Debt$66.5K$1.03B
    Long-Term Debt$98.5K$50.28M
    Long-Term Leases$27.0K$246.9K$188.8K$140.1K
    Total Liabilities$43.09M$27.90M$16.91M$18.20M$19.79M$46.74M$101.90M$50.77M$36.58M
    EquityCommon Stock & APIC$90.3K$286.1K$1.27M$1.76M$2.27M$130.1K$239.1K$538.9K$1.87M
    Retained Earnings-$216.31M-$254.48M-$289.72M-$342.88M-$408.94M-$467.92M-$543.28M-$605.71M-$653.54M
    Total Equity-$25.54M-$16.13M$2.83M$4.61M$8.74M-$14.44M-$73.08M-$32.19M-$10.39M
    HighlightsNet Cash / (Debt)$1.55M-$1.07B

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$33.04M-$32.29M-$31.79M-$54.25M-$56.67M-$42.97M-$68.79M-$51.83M-$56.15M
    Cash from Investing-$2.78M-$437.3K-$900.0K
    Cash from Financing$34.35M$39.03M$37.21M$56.19M$59.59M$48.97M$60.33M$44.98M$60.60M
    SummaryCapital Expenditure-$2.78M-$437.3K
    Free Cash Flow-$35.82M-$32.73M
    FCF Margin-1160.2%-401.8%

    Ratios